Mgbe ntiwapụ nke ọrịa COVID-19 gasịrị, Kọmitii nchịkwa nke Zhongguancun Science Park wepụtara ndepụta teknụzụ, ngwaahịa na ọrụ ọhụrụ iji wusie nkwado sci-tech maka ọgụ megide ọrịa a.Ụgwọ nke ụlọ ọrụ TIANGEN BIOTECH (BEIJING) CO., LTD.bụ na ndepụta ọnụ na ndị ọzọ.
Ngwaahịa na ọrụ teknụzụ dị na ndepụta a na-ekpuchi ọtụtụ akụkụ metụtara ịlụso ọrịa ọgụ ọgụ, dị ka nchọpụta nje, R&D ọgwụ mgbochi, ọgwụgwọ ụlọ ọgwụ, nchekwa ahụike, nyocha ọgụgụ isi, yana nyocha na mwepụta data ọrịa.
N'ọnwa Maachị, otu kọlụm "Beijing Site na Train" nke BTV gbara TIANGEN BIOTECH ajụjụ ọnụ na saịtị banyere ọgụ biochemical ya na-alụ megide ọrịa a.Ekwusala akụkọ a na mmemme "Beijing Site na Train" nke ọwa ego BTV na Eprel 12.
Dị ka ihe upstream soplaya nke nucleic acid mmịpụta na nchọpụta reagent akụrụngwa na China, TIANGEN BIOTECH (BEIJING) CO., LTD.akwadowo nyocha na mgbochi nke ọrịa nje na China ugboro ugboro, ma nyekwa akụrụngwa isi maka nchọpụta nje nke ihe karịrị nde mmadụ 10 na nchọpụta nke ọrịa HFMD na H1N1.Na 2019, TIANGEN BIOTECH wetara ozuzu ezì na nkeji iche iche na ndị na-ewepụta acid nucleic na-akpaghị aka na mmịpụta nucleic acid na ihe nchọpụta ihe karịrị nde ezì 30.
Oge nzipu: Jan-05-2022
